...February 8, 2021 NEW YORK (S&P Global Ratings) Feb. 8, 2021--S&P Global Ratings said today that Akumin Inc.'s proposed $75 million fungible add-on to its senior notes is leverage neutral and does not affect any of the ratings on the company, including issue-level ratings. We expect proceeds will be primarily used to fund growth-related activities including tuck-in acquisitions. Our 'B-' issuer credit rating and stable outlook on Akumin reflect our expectation that patient volume growth will steadily improve amid the ongoing COVID-19 pandemic, leading to low- to mid-single-digit percent organic growth over the next two years. We also expect the company to continue its acquisition strategy to increase market density, market share, and operating efficiencies....